Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260827 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
On both cards: Used for — Type 2 diabetes in adults, as an adjunct to diet and exercise · Common side effects — Headache
Only on the Glimepiride card: Common side effects — Hypoglycemia; Nausea; Dizziness; Asthenia · Warnings — Severe hypoglycemia; Hypersensitivity incl. sulfonamide allergy; Hemolytic anemia in G6PD deficiency · Interactions — Oral miconazole (severe hypoglycemia); CYP2C9 inhibitors and inducers; Colesevelam
Mechanism: A DPP-4 inhibitor believed to act by slowing incretin inactivation. It increases and prolongs active GLP-1 and GIP levels, which influence insulin and glucagon in a glucose-dependent manner.
On both cards: Common side effects — Upper respiratory tract infection; Headache
Only on the Sitagliptin card: Used for — Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes · Common side effects — Nasopharyngitis · Warnings — Pancreatitis; Heart failure; Acute renal failure · Interactions — Insulin or insulin secretagogues (sulfonylureas)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera